Worst of Reverse Convertible

Symbol: OWRRCH
ISIN: CH1373307086
Issuer:
Raiffeisen
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.
Price Time-delayed price
20.02.26
22:15:00
- %
- %
USD
Volume
0
0
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 46.73
Diff. absolute / % 0.00 0.00%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Worst of Reverse Convertible
ISIN CH1373307086
Valor 137330708
Symbol OWRRCH
Quotation in percent Yes
Coupon p.a. 10.00%
Coupon Premium 6.37%
Coupon Yield 3.63%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached Yes (Novo Nordisk AS (B) - 27/03/2025)
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 20/09/2024
Date of maturity 20/03/2026
Last trading day 13/03/2026
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Dirty
Issuer Raiffeisen

Key data

Sideways yield p.a. -

market maker quality Date: 18/02/2026

Average Spread -
Last Best Bid Price 35.68 %
Last Best Ask Price - %
Last Best Bid Volume 250,000
Last Best Ask Volume 0
Average Buy Volume 0
Average Sell Volume 0
Average Buy Value 0 USD
Average Sell Value 0 USD
Spreads Availability Ratio 0.00%
Quote Availability 99.96%

Underlyings

Name Eli Lilly & Co. Merck & Co. Inc. Novo Nordisk AS (B)
ISIN US5324571083 US58933Y1055 DK0062498333
Price 900.00 CHF 103.90 EUR 40.2125 EUR
Date 09/02/26 16:26 21/02/26 13:04 21/02/26 13:02
Cap 923.71 USD 115.86 USD 918.50 DKK
Distance to Cap 82.97 6.07 -611.1
Distance to Cap in % 8.24% 4.98% -198.80%
Is Cap Level reached No No No
Barrier 498.803 USD 62.5644 USD 495.99 DKK
Distance to Barrier 507.877 59.3656 -15.39
Distance to Barrier in % 50.45% 48.69% -3.20%
Is Barrier reached No No Yes

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.